Medical Management of Type 2 Diabetes
68,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

In this new edition of an essential text, diabetes experts define the progressive nature of type 2 diabetes; examine cardiovascular, microvascular, and neurologic complications, describe care methdologies for special situations, such as pregnency and hospitalization; and illustrate methods of behavior change. This book will enhance clinical knowledge of type 2 diabetes and bolster the skills necessary to care for patients with diabetes. The eighth edition features: 1. Details on the newest agents for the treatment of type 2 diabetes 2. Expanded information on pharmacological intervention 3.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
In this new edition of an essential text, diabetes experts define the progressive nature of type 2 diabetes; examine cardiovascular, microvascular, and neurologic complications, describe care methdologies for special situations, such as pregnency and hospitalization; and illustrate methods of behavior change. This book will enhance clinical knowledge of type 2 diabetes and bolster the skills necessary to care for patients with diabetes. The eighth edition features: 1. Details on the newest agents for the treatment of type 2 diabetes 2. Expanded information on pharmacological intervention 3. Updated data on chronic and acute complications 4. The latest standards of medical care from the American Diabetes Association
Autorenporträt
Luigi Meneghini, MD, MBA, is a Professor of Internal Medicine at the University of Texas Southwestern Medical Center, Division of Endocrinology, in Dallas, Texas, and Executive Director of the Parkland Health and Hospital System Global Diabetes Program. Prior to joining UT Southwestern, he was he was Professor of Clinical Medicine at the University of Miami Miller School of Medicine and Director of the Kosow Diabetes Treatment Center. Dr. Meneghini is a frequent lecturer and has published numerous articles in peer-reviewed medical journals. He has presented numerous projects at the Scientific Sessions of the American Diabetes Association and the European Association for the Study of Diabetes. Dr. Meneghini¿s primary interests lie in improving the lives of patients with diabetes through the application of cutting edge therapies and technologies, and the implementation of these treatment strategies through patient and professional education activities.